![](/img/cover-not-exists.png)
Phase II study of 90 Y Ibritumomab tiuxetan (Zevalin) in patients with previously untreated marginal zone lymphoma
Lossos, Izidore S., Fabregas, Jesus C., Koru-Sengul, Tulay, Miao, Feng, Goodman, Deborah, Serafini, Aldo N., Hosein, Peter J., Stefanovic, Alexandra, Rosenblatt, Joseph D., Hoffman, James E.Volume:
56
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2014.975801
Date:
June, 2015
File:
PDF, 214 KB
english, 2015